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ABSTRACT 
COMPARATIVE ANALYSIS OF ANTIVIRAL RESPONSES IN MOUSE 
EMBRYONIC STEM CELLS AND IN MESENCHYMAL STEM CELLS 
by Jundi Wang 
August 2013 
Embryonic stem cells (ESCs) are cells that have unlimited capacity for self-
renewal and differentiation. These properties make ESCs a great cell source for 
application in regenerative medicine. When used for cell therapy, ESC-derived cells 
could be placed in a wounded area that is likely to be exposed to various pathogens. 
However, it is not well-understood whether ESCs and ESC-derived cells have active 
antiviral responses against infectious agents from the environment. To answer this 
important question, I comparatively analyzed the antiviral responses of ESCs and 
mesenchymal stem cells (MSCs, C3H10Tl/2 cell line) to infectious agents. Using the 
expression of type I interferon (IFN) as a benchmark of antiviral responses, our results 
indicated that the type I IFN were robustly induced in C3Hl0Tl/2 cells, but not in ESCs, 
when they were exposed to polyinosinic:polycytidylic acid (poly(I:C), a dsRNA viral 
analog) and La Crosse Virus (LACV). Our results also showed that TLR3, RIG! and 
MDA5, the receptors for viral RNA, are expressed at lower levels in mouse ESCs 
(mESCs) than in C3H10Tl/2 cells. However, mESCs are susceptible to LACV infection 
resulting in cell death, which can be reduced by IFNP pretreatment. Furthermore, IFNP 
induced expression of ISG 15, PKR and dsRNA receptor genes that play key roles in 
antiviral responses. In conclusion, mESCs are deficient in type I IFN expression, but 
they have functional mechanisms that mediate the antiviral effects of type I IFN. 
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CHAPTER I 
INTRODUCTION 
Embryonic Stem Cell 
1 
Embryonic stem cells (ESCs) have been intensively studied for the past several 
years due to their pluripotency and self-renewal capacity (Wobus & Boheler, 2005; 
Keller, 2005). Pluripotency is a unique property of ESCs that allows them to differentiate 
into any of the three germ layer cells. Therefore, ESCs are considered a promising cell 
source for regenerative medicine. ESCs are derived from an early developmental stage of 
the embryo called a blastocyst, which consists of outer trophoblast cells surrounding the 
inner cell mass (ICM). The ICM is composed of undifferentiated cells with the ability to 
form the three primary germ layers (endoderm, mesoderm and ectoderm), which will 
further differentiate to all tissues and organs (Fig. 1). 
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Figure 1. ESCs and Their Differentiation Potential (Wobus & Boheler, 2005) 
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Maintenance of pluripotency without further differentiation is necessary for the 
study of ESCs. Under in vitro culture conditions, ESCs require leukemia inhibitory factor 
(LIF) which prevents ESCs differentiation by binding to heterodimeric receptors and 
results in the activation of the JAK/STAT (Janus kinase-signal transducer and activator of 
transcription) pathway, which is essential and sufficient to maintain the pluripotency of 
ESCs (Niwa, 2007). Pluripotency refers to the capacity of ESC differentiating to different 
cell lineages (Wobus & Boheler, 2005; Keller, 2005). In the absence LIF, ESCs can 
differentiate into specialized cell types such as dendritic cells, cardiomyocytes, 
endothelial cells, neurons, smooth muscle cells and hepatocytes if proper conditions are 
provided (Ying, Stavridis, Griffiths, Li & Smith, 2003; Maltsev, Wobus, Rohwedel, 
Bader, & Hescheler, 1994; Risau et al, 1988; Lee, Lumelsky, Studer, Auerbach, & Mc 
2000; Drab et al, 1997; Jones, Tosh, Wilson, Lindsay, & Forrester, 2002; Fairchild et al, 
2000). Self-renewal is defined as the ability of ESCs to divide indefinitely while 
maintaining pluripotency (He, Nakada, & Morrison, 2009). It is well established that the 
self-renewal and pluripotency in ESCs are mainly regulated by a set of transcriptional 
factors, including Oct4, Sox2 and Nanog. The Oct4-Sox2-Nanog transcriptional 
regulatory network forms a positive feedback loop which allows these transcription 
factors to regulate each other by binding to anyone of their promoter regions, and 
negatively regulates the expression of differentiation promoting genes (Smith, 2001). 
Moreover, it has been reported that Oct4 and activated JAK/STAT3 pathway can 
cooperatively induce Kruppel-like factors such as klf 2, 4, and 5 to maintain ESC self-
renewal (Pinney & Emerson, 1989). Therefore, Oct4, Nanog and Sox2 play the most 
important roles in maintain the properties of ESCs. 
3 
The self-renewal capacity and pluripotency give ESCs great potential in the field 
of regenerative medicine. Many studies have reported that ESCs-derived cells have the 
potential to treat human diseases, such as neurodegeneration, diabetes, and myocardial 
infarction (Svendsen & Smith, 1999; Soria et al, 2000; Klug, Soonpaa, Koh, & Field 
1996). However, there are many obstacles still need to be overcome before ESCs are used 
as a source of cell based therapy. For example, it is known that self-renewal of 
undifferentiated ESCs can result in the development of teratomas if unpurified ESC-
derived cells are transplanted into the patient (Keller, 2005). Furthermore, the issue of 
immunological rejection needs to be resolved, as it will cause the destruction of 
transplanted cells via activation of the recipient's immune system. Antiviral responses 
have been extensively studied in other types of cells, but whether or not ESCs and ESC-
derived cells have any functional innate immunity has not been investigated. Since ESCs 
are normally residing in a sterile environment of the womb, they may not be exposed to 
pathogens from the outside environment during the early stage of development (Levy, 
2007). However, for purposes of clinical application, ESCs must be differentiated and 
purified in vitro before being transplanted into patients. After transplantation, these cells 
will be potentially challenged by the infectious agents ; therefore, the capacity of innate 
immunity is critical for the functionality and survival of implanted cells. As already 
suggested by previous studies, human ESCs (hESCs) and hESC-derived endothelial cells 
do not have mature immune function (Foldes et al., 2010; Chen, Yang, & Carmichael, 
2010). The molecular basis of the innate immunity deficiency in ESCs has not yet been 
studied in details. The objective of this project is to investigate the antiviral responses as 
a critical part of innate immunity in mouse ESCs (mESCs). 
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Mesenchyrnal Stern Cells 
Compared with ESCs, MSCs are more differentiated stern cells which can 
respond to different infectious agents. MSCs are adult stern cells with limited capacity of 
self-renewal and differentiation to closely related cell lineages (Williams & Hare, 2011). 
They were initially isolated from the bone marrow strorna, which have the potential to 
differentiate into rnesoderrn-derived cells, such as osteoblasts, chondrocytes, adipocytes, 
and rnyotubes (Williams & Hare, 2011 ; Minguell, Erices, & Conget, 2001). It is now 
known that MSCs exist in different tissues, such as umbilical cord blood, adipose tissue, 
and epithelial tissues (Ren et al., 2012; Lee et al., 2004; Jiang et al., 2002). Therefore, 
MSCs are also regarded as promising source of cell-based therapy for a wide range of 
degenerative diseases. 
The C3H lOTl/2 cells were established in 1973 from 14- to 17-day old C3H 
mouse embryos. These cells display fibroblastic morphology in cell culture and are 
functionally similar to MSCs that can differentiate several cell types, such as adipocytes, 
pericytes/srnooth muscle cells, and endothelial cells (Proweller, Pear, & Parrnacek, 2005; 
Pinney & Emerson, 1989; Wang et al., 2010; Tang, Otto, & Lane, 2004). In this project, 
C3H lOTl/2 cells, a well-characterized MSC line that are highly responsive to different 
infectious agents (Wang et al., 2013), will be used for comparative analysis of the innate 
immunity in rnESCs. 
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Antiviral Responses 
Antiviral response is a critical component of innate immunity and plays very 
important roles against viral infections. Innate immunity and adaptive immunity are two 
components of the immune system. Innate immunity is the first line of an organism's 
defense against infectious agents. The innate immunity system is composed of 
mechanical, chemical and cellular elements. In mechanical element, the physical barrier, 
such as epidermis and mucosa, protects the organism from pathogens invasion. The 
chemical element is divided into three components: pathogen recognition, proteins or 
peptides-mediated microbe hydrolysis, and cytokines and chemokines that orchestrate the 
immune response. The third element is the cellular element, which includes epithelial 
cells, mast cells, dendritic cells, NK cells and phagocytic cells. These cells form a 
complicate antiviral network to protect organisms from infectious agents by different 
mechanisms (Basset, Holton, O'Mahony, & Roitt, 2003). In this project, we will focus on 
the study of antiviral responses in ESCs and MSCs. 
It was well-established that innate immunity plays an important role in the 
pathogen-recognition and subsequent signaling transduction to protect cells from 
pathogenic attacks (Medzhitov & Janeway, 2000). Innate immunity can immediately 
respond to invading pathogens by recognizing conserved structures termed pathogen-
associated molecular patterns (PAMPs) (Mogensen, 2009). During early innate immune 
activation, these PAMPs will be detected by pattern-recognition receptors (PRRs), 
proteins expressed on the cell surface or in the cytosol. After PRR activation, the 
downstream signaling pathways are triggered by activating a multitude of transcription 
factors, such as interferon regulatory factors (IRFs) and nuclear factor-KB (NF-KB), 
which coordinately regulate the expression of type I interferon (IFN) and cytokines 
(Alcira, Uematsu, & Takeuchi, 2006). Through paracrine and autocrine signaling, IFNs 
and cytokines participate in different aspects of innate immune as well as adaptive 
immune responses (Mogensen, 2009). 
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The members of toll-like receptors (TLRs) family are the major class of PRRs and 
are expressed on the cell surface or the membranes of endosomes in most cell types 
(Miettinen, Sareneva, Julkunen, & Matikainen, 2001). TLRs are composed of an 
extracellular ligand-binding domain, which recognizes and binds to the conserved 
structures of pathogens, and a cytoplasmic Toll/interleukin-1 receptor homology (TIR) 
domain that plays an important role in signal transduction (Carty & Bowie, 2010). After a 
ligand binds to TLRs, adaptor molecules are recruited to the cytoplasmic domain of TLRs 
and trigger downstream signal pathways (Mogensen, 2009). So far, 10 members of the 
TLR family have been identified in mice (designated TLRl through TLRlO). TLRl, 2, 4, 
5, 6, and 10 mainly detect bacterial components (Mogensen, 2009; Jin et al., 2007; Kim 
et al., 2007). The rest of the TLRs (TLR3, 7, 8, and 9) mainly recognize nucleic acids 
(Liu et al., 2008; Kawai & Alcira, 2008). 
The Retinoic Acid-Inducible Gene-I-like receptors (RLR) are another family of 
PRRs. All RLR members are expressed in the cytoplasm. Retinoic Acid-Inducible Gene-I 
(RIG-I), Melanoma Differentiation-Associated Gene 5 (MDA5), and Laboratory of 
Genetics and Physiology 2 (LGP2) are the members of the RLR family. Although aH of 
these receptors can detect dsRNA, RIG-I preferentially detects short dsRNA and MDA5 
mainly binds to long dsRNA (Kato et al, 2008; Pippig et al, 2009). The structure of RLRs 
consists of a DExH/D (Asp-Glu-X-His/Asp)-box RNA helicase domain and a C-terminal 
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domain (Mogensen, 2009; Matsumiya & Stafforini, 2010). Two Caspase Activation and 
Recruitment Domains (CARDs) are located at the N-termini of RIG-I and MDA5, but 
LGP2 lacks a CARD domain (Yoneyama & Fujita, 2007). In the inactivated 
conformation, the C-terminal domain of RLR prevents CARDs from binding to the 
downstream adaptor molecules until RLR binds to viral dsRNA (Matsumiya & Stafforini, 
2010; Yoneyama & Fujita, 2007; Saito et al., 2007). The binding of dsRNA to the C-
terminal domains results in conformational change in C-terminal domain of RIG-I or 
MDA5. Then, the CARDs will be released and binds to the adaptor protein such as IFN~ 
promoter stimulator 1 (IPS-1) at the mitochondrial membrane to ultimately activate 
transcription factors that lead to the antiviral response (Matsumiya & Stafforini, 2010). 
Double stranded RNA-activated protein kinase (PKR) is composed of two 
functional domains, an N-terminal dsRNA binding domain (dsRBD) and a C-terminal 
kinase domain containing the major phosphorylation site (Nallagatla, Toroney, & 
Bevilacqua, 2011). It plays important roles in antiviral response. The viral dsRNA is 
recognized by the dsRNA binding motifs (dsRBM) located at N-terminal dsRBD via 
minor groove interactions. The binding of viral dsRNA causes conformational changes in 
PKR and leads to autophosphorylation and dimerization. In addition to selectively 
activating the transcription of genes involved in the immune responses, PKR also causes 
a general inhibition of transcription, translation and host cell proliferation that limit viral 
replication (Mogensen, 2009). Table 1 lists the major microbial components and PRRs. 
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Table 1 
Recognition of Microbial Components by PRRs 
Receptor Cellular PRR-Recognized Microbial Species of 
Localization Com2onent(s) Microorganism(s) 
TLRs 
Cell surf ace Triacyl lipopeptides Bacteria 
TLRJITLR2 
Cell surface Diacyl Lipopeptides Mycoplasma 
TLR2/TLR6 
Lipoteichoic acid Gram-positive 
Bacteria 
TLR2 Cell surf ace Lipoprotein Various pathogens 
Peptidogl ycan Gram-positive and 
negative bacteria 
Lipoarabinomannan Mycobacteria 
Porins Neisseria 
Envelope glycoproteins Viruses 
GPI-mucin Protozoa 
Phospholipomannan Candida 
Zymosan Fungi 
~-Glycan Fungi 
TLR3 Cell surface dsRNA Viruses 
Endosomes 
TLR4 Cell surface LPS Gram-negative 
bacteria 
Envelope gl ycoproteins Viruses 
Glycoinositolphospholipids Protozoa 
Mannan Candida 
HSP70 Host 
TLR5 Cell surf ace Flagellin Flagellated bacteria 
TLR7/8 Endosome ssRNA RNA viruses 
TLR9 Endosome CpGDNA Viruses, bacteria, 
protozoa 
RLRs 
RIG-I Cytoplasm dsRNA (short), Viruses 
5' -triphosphate RNA 
MDA5 Cytoplasm dsRNA (long) Viruses 
Miscellaneo 
us 
PKR Cytoplasm dsRNA, Viruses 
5' -triehosehate RNA 
9 
After PRRs bind to their ligands, a number of different signaling pathways are 
activated depending on the binding of different sets of adaptor molecules. As shown in 
Figure. 2. In TLR-induced signaling pathways, ligand binding induces TLR dimerization 
and binding of adaptor molecules to the cytoplasmic TIR domain, such as Myeloid 
differentiation factor 88 (MyD88) or TIR-domain-containing adapter-inducing IFN~ 
(TRIP) following the binding of a ligand (Mogensen, 2009). MyD88 and TRIP are 
involved in regulating inflammatory genes and type I IFN expression. In the case of the 
signaling pathway mediated by TLRl, 2, 4, 5, 6, 7, 8, and 9, MyD88 binds to the TIR 
domain of the TLR and phosphorylates Interleukin-1 receptor-associated kinase (IRAK) 
and transforming growth factor-activated protein kinase 1 (TAKl), causing the activation 
of either the NF-KB or MAPK pathway (Mogensen, 2009; Bums et al., 1998). On the 
other hand, TRIP plays essential roles in TLR3 mediated antiviral pathway. The 
recognition of viral dsRNA by TLR3 recruits TRIP to the receptor. It was reported that 
the binding of TLR4 and bacterial component can also trigger TRIP-mediated 
downstream pathway. Then, TRIP binds to TNFR-associated factor 6 (TRAF6) and 
receptor-interacting protein 1 (RIP1) and ultimately activates the NF-KB and IRF3/7 
pathway (Akira et al., 2006). 
In the RLR mediated signaling pathway, dsRNA binding triggers signaling via 
CARD-CARD interaction between the receptor and the adaptor protein IPS-1 
(Matsumiya & Stafforini, 2010). Then, the TNF receptor-associated death domain 
(TRADD) recruits to IPS-1 and forms IPS-1-TRADD complex (Michallet, 2008), which 
eventually phosphorylates IRF3 and IRF7 through the activation of TANK-binding 
kinase 1 (TBKl) / I-K13 kinase c (IKKc) (Takahashi et al, 2006), which leads to the 
expression of type I IFN and cytokines. 
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Figure 2. The Signaling Pathways Involved in Innate Immunity (Mogensen, 2009). 
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Type I IFN (IFNa and IFN~) gene expression is mainly mediated by PRR 
signaling pathways via activation of IRF3 and IRF7 (IRF3/7) (Akira et al., 2006; 
Yoneyama et al., 1998). As shown in Figure 3, IFNa and IFN~ are secreted into the 
surrounding tissue. Depending on the state of the cell, they affect different physiological 
events via autocrine and paracrine signaling mechanisms. In normal cells, type I IFN 
11 
have been demonstrated to play important roles in inhibiting viral replication (Siren, 
Pirhonen, Julkunen, & Matikainen, 2005). On the other hand, type I IFN may cause the 
death of the infected cells as a mechanism of antiviral response (Takaoka & Yanai, 
2006). Although type I IFN are best known for their antiviral activities, they also regulate 
several other cellular activities, such as cell differentiation (Boo & Yang, 2010; Clemens 
& McNurlan, 1985) . 
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Figure 3. The Overview of the Signaling Network for Type I IFN in Innate Immunity 
(Takaoka & Yanai, 2006). 
12 
Signaling Pathway Activated by Type I Interferon 
As mentioned above, the PRR-mediated antiviral pathways can activate NF-KB 
and IRF3/7, and induce expression of type I IFN. Once secreted, IFN bind the interferon-
alpha/beta receptor (IFNAR) (Boo & Yang, 2010), which recruits and activates JAK and 
leading to STATl and STAT2 phosphorylation (De et al., 2001). The phosphorylated 
STATl and STAT2 translocate into the nucleus and induced the expression of numerous 
genes, known as interferon-stimulated genes (ISGs). The best studied ISGs include Mx 
proteins, PKR, and 2',5'oligoadenylate, which play key roles in antiviral responses. 
Mx proteins are a small family of GTPases. A unique property of Mx GTPases is 
their antiviral activity against a wide range of RNA viruses, such as Influenza and some 
members of the Bunyavirus family (Haller, Staeheli, & Kochs, 2007). GTP-binding and 
carboxy-terminal effector functions of Mx protein play important roles in recognizing 
viral nucleocapsid-like structures. Eventually, these viral nucleocapsid proteins are 
trapped and sorted into locations where they become unavailable for the generation of 
new virus particles (Haller & Kochs, 2002). As previously mentioned, activated PKR 
phosphorylates eukaryotic initiation factor 2 alpha (eIF2a) and blocks viral gene 
translation via protein synthesis inhibition (Nallagatla et al., 2011). Whereas, 
2',5'oligoadenylate activates RNase L that causes degradation of viral RNA thereby 
inhibiting viral replication (Boo & Yang, 2010; Li, Blackford, & Hassel, 1998). 
CHAPTER II 
OBJECTIVE AND SIGNIFICANCE 
13 
ESCs have attracted enormous attention in recent years with the expectation that 
they could be used as a source for cell-based therapy. While the benefit of research on 
ESCs in medical applications is exciting, currently there is limited understanding of the 
basic physiology of ESCs and their derived cells. When used for cell therapy, ESC-
derived cells would be placed in a wounded area that is likely to be exposed to various 
pathogens. Therefore, their fate and functionality may depend on their innate antiviral 
responses to deal with a hostile environment. Innate immunity as the first line of defense 
has been intensively investigated in a wide variety of somatic cells. It is generally 
believed that most cell types, if not all, have acquired innate immunity. However, recent 
studies indicated that ESCs do not respond to a wide range of infectious agents including 
bacterial LPS and dsRNA (Foldes et al., 2010; Chen et al, 2010). Our recent study 
demonstrated mESCs are unable to express type I IFN when exposed to viral infections, 
indicating that they do not have functional antiviral mechanisms (Wang et al., 2013). 
Surprisingly, we recently found that ESCs are able to respond to IFN~ and express the 
genes that confer antiviral activities. However, the molecular mechanisms involved have 
not been elucidated. The proposed study aims to understand the antiviral responses of 
ESCs and how they are affected by the antiviral effect of IFN. This study may open up an 
important area in ESC research for understanding the development of antiviral 
mechanisms during embryogenesis and how the immunogenic signals affects ESC 
physiology. The findings from this study could provide valuable information to prepare 
ESC-derived cells for their application in regenerative medicine. 
CHAPTER III 
METHODS 
Cell Culture 
14 
mESCs (D3 cell line) were obtained from ATCC. They are used for the majority 
of the experiments in this study and maintained in Dulbecco's modification of Eagles's 
medium (DMEM) (Mediatech, Inc., Manassas, VA) containing 15% fetal bovine serum 
(FBS) (ATLANTA biological, Lawrenceville, GA) with leukemia inhibitory factor (LIF) 
(EMD Millipore Corporation, Billerica, MA) and 100 unit/mL penicillin and 100 µg/mL 
streptomycin. They were routinely maintained in cell culture dishes coated with 0.1 % 
gelatin. C3H10Tl/2 cells were cultured in minimum essential medium (MEM) 
(Mediatech, Inc., Manassas, VA) containing 10% FBS and antibiotics at the 
concentrations mentioned above. All cells were maintained at 37 °Cina humidified 
incubator with 5% CO2. 
Cell Treatment 
D3 and C3H10Tl/2 cells were plated at -40% and -70% confluence, 
respectively, and cultured for 24 h before the experiments. Poly(I:C) (Sigma-Aldrich, St. 
Louis, MO) was transfected into the cells with DharmaFECT reagent (Thermo Scientific, 
West Palm Beach, FL). For poly(l:C) transfection experiments, control cells were 
transfected with DharmaFECT reagent only. For viral infection, LACY (a gift from Dr. 
Fengwei Bai, The University of Southern Mississippi) viral stocks were added to the cell 
culture at the concentrations as specified in individual experiments. The culture medium 
and treated cells were collected at different time periods and used for various analyses. 
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Spectrophotometric Analysis of Cell Viability 
Cell viability was determined by colony size and by cell number after toluidine 
blue (TB) staining. The cells treated with poly(l:C) were fixed with methanol for 15 
minutes. The cells collected from the live virus infection experiments were treated with 
2% paraformaldehyde (PFA) first for virus inactivation. After PFA treatment, the cells 
were similarly fixed with methanol for 15 minutes. The cells were stained with TB for 30 
minutes after phosphate buffered saline (PBS) (Thermo Scientific, West Palm Beach, FL) 
washing. After 30 min incubation, the cells were washed with water and air-dried, 
followed by using 2% sodium dodecyl sulfate (SDS) to extract the TB. OD630 value was 
measured by a Bio-Tek Instruments ELX800 microplate reader and analyzed with KC 
junior software (Bio-Tek Instruments, Inc, Winooski, VT). 
R~al-Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
Total RNA was extracted using Tri-reagent (Sigma-Aldrich, St. Louis, MO). 
cDNA was prepared by M-MLV reverse transcriptase (Promega, Madison, WI). RT-
qPCR was performed using SYBR green ready mix (Bio-Rad; Hercules, CA) on a 
MX3000PTM RT-PCR system (Stratagene, La Jolla, CA). The mRNA level from RT-
qPCR was calculated using the t1t1Ct method (Pfaffl, 2001).13-actin mRNA was used as a 
calibrator for the calculation of relative mRNA of the tested genes. Sequences of gene-
specific primers are listed in Table 2. 
16 
Table 2 
Sequences of Gene-specific Primers 
Gene Forward Primer Reverse Primer 
IL-6 TAGTCCTfCCfACCCCAATITCC TfGGTCCTfAGCCACTCCTfC 
IFN~ CCCTATGGAGATGACGGAGA ACCCAGTGCTGGAGAAATfG 
IFNa CTGCTGGCTGTGAGGACATA AGGAAGAGAGGGCTCTCCAG 
RIG-I ATfCAGGAAGAGCCAGAGTGTC GTCTfCAATGATGTGCfGCAC 
MDA5 CGATCCGAATGATfGATGCA AGTfGGTCATfGCAACTGCf 
TLR3 CTfGCGTfGCGAAGTGAAGAA CCAATfGTCfGGAAACACCCC 
TLR4 TGCACTGAGCfTTAGTGGTfGC GACCCATGAAATTGGCACTCAT 
Oct4 AGTfGGCGTGGAGACTITGC CAGGGCTITCATGTCCfGG 
Nanog TfGCTfACAAGGGTCTGCTACT ACTGGTAGAAGAATCAGGGTC 
Sox2 GACAGCTACGCGCACATGA GGTGCATCGGTTGCATCTG 
PKR AAGCAGGAGGCAAGAAACG TGACAATCCACCTfGTfTTCGT 
ISG15 AGGTCTITCfGACGCAGACTG GGGGCTITAGGCCATACTCC 
IFNAR GACAACTACACCCTAAAGTGGAG GCTCfGACACGAAACTGTGTfTT 
Protein Analysis by Flow Cytometry 
To determine the protein level by fluorescence labeling, treated cells were 
released by 0.25% Trypsin-EDT A (GIBCO, Grand Island, NY) and fixed with 80% 
ethanol for 30 minutes at 4°C, then washed with PBS that contains 2% bovine serum 
albumin (BSA) (Sigma-Aldrich, St. Louis, MO) for 20 minutes. Cells were incubated 
with primary antibodies (ICAMl) (Santa Cruz Biotechnology, Inc. , Santa Cruze, CA) at 
1: 100 dilution in PBS containing 2% BSA for 2 h at room temperature. The cells were 
then incubated with secondary antibodies conjugated with FITC (1 :100) (Santa Cruz 
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Biotechnology, Inc., Santa Cruze, CA) in PBS with 2% BSA for 1 hat room temperature. 
The cell suspension was examined through an Accuri C6 flow cytometer. The 
fluorescence intensity, which correlates with the protein level, was determined with 
CFlow software (BD Accuri Cytometers, Inc., Ann Arbor, Ml). 
IFNP and Cytokine Assay 
The culture medium collected from treated cells was used to determine secreted 
IFNP and cytokines. IFNP was quantified with an Enzyme-lined Immune Sorbent Assay 
(ELISA) kit (PBL interferon source, Piscataway, NJ) that detects mouse IFNP according 
to the manufacturer's instruction. IL6 was analyzed with a Luminex cytokine assay kit 
(EMD Millipore Corporation, Billerica, MA) and determined with a MAGPIX instrument 
(EMD Millipore Corporation, Billerica, MA). The data was analyzed according to the 
method described by Parbhakar et al. (Prabhakar, Eirikis, & Davis, 2002). 
Plaque Assay 
Titers of LACV in culture medium collected from infected cells were determined 
in vero cells by plaque assay as described by Bai et al (Bai et al., 2005). Briefly, 95-100% 
confluent vero cells were infected with lOOOOx dilution of culture medium collected from 
infected cells and incubated at 37°C in 5% CO2 incubator for lh. After virus adsorption, 
medium was removed completely and cells were overlaid with DMEM-agarose and 
further incubated for 4 days. The plaques were counted after staining with second overlay 
containing 4% (vol/vol) neutral red. 
CHAPTERIY 
RESULTS 
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In order to determine the antiviral responses in mESCs, we treated the cells with 
two commonly used two agents. Poly(I:C) is a synthetic double-stranded RNA used as a 
viral analog. In many publications, poly(I:C) has been shown to activate antiviral 
responses via binding to RIG-I, MDA5, TLR3, and PKR (Heim, 2005; Hu et al., 2011; 
Zimmer, 2011). It has also been reported that poly(I:C) can cause cell cycle interruption 
via PKR-induced eIF2a phosphorylation, which results in protein synthesis inhibition 
(Garcia, Meurs, & Esteban, 2007). LACY belongs to Bunyaviridae family, which can 
cause encephalitis. The LACY genome is composed of three single-stranded, negative-
sense RNA segments. Although poly(I:C) is commonly used to mimic a viral infection, it 
is a synthetic compound which may not reflect antiviral response of ESCs under the 
physiological conditions. Therefore, LACY, a live virus, is chosen for this study since it 
is known to cause lytic cell death of mammalian cells (Yerbruggen et al., 2011). It has 
been shown that LACY can activate PKR and induce eIF2a phosphorylation in 
fibroblasts (Streitenfeld et al., 2003). Additionally, the non-structured protein of LACY 
can also induce mitochondrial cytochrome C release and Caspase activation in cell-free 
extracts and promote neuronal apoptosis and mortality in a mouse model (Colon-Ramos 
et al., 2003). 
Double Stranded RNA (dsRNA) Transfected to Mouse ESCs (mESCs) Inhibits Cell 
Proliferation 
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We transfected poly(l:C) into mESCs since this is a commonly approach that 
induce antiviral responses in many cell types. The most notable effect of transfected 
poly(l:C) on mESCs at the cellular level was the inhibition of cell proliferation. As 
shown in Fig. 4A, the colonies of poly (I:C)-transfected cells were much smaller than the 
control colonies as determined by microscopic analysis (Fig. 4A), correlating with 
markedly reduced cell numbers determined by toluidine blue cell staining (Fig. 4B, left 
panel). The proliferation inhibition effect of transfected poly(l:C) was also found in 
C3HI0Tl/2 cells (Fig. 4B, right panel). 
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Figure 4. Effects of poly(I:C) on mESC colony formation and cell proliferation. A and B) 
Cells were transfected with 300 ng/mL poly(I:C). Control (Con) represents cells 
transfected with DharmaFECT without poly(I:C). A) After incubation for 40h, the 
colonies were examined under a phase contrast microscope and photographed with a 
digital camera (lOOx, upper panels; 400x, lower panels). B) Cell proliferation was 
measured by cell number indirectly determined from toluidine blue staining (absorbance 
at 630 nm). The values are means ± SD of an experiment performed in biological 
triplicate (B). 
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mESCs Fail to Express and Produce IFNP, IL-6, and ICAMl in Response to dsRNA 
We analyzed the mRNA levels of IFNP, intercellular adhesion molecule 1 
(ICAMl), and proinflammatory cytokine gene such as Interleukin-6 (IL-6) in the cells 
transfected with poly(l:C). The mRNA levels of IL-6 and IFNP were negligible in 
mESCs compared with C3H10Tl/2 cells (Fig. 5A and B). When examined at the protein 
level by ELISA and Luminex assay, neither IFN~ nor IL-6 was detected in the medium 
collected from poly(l:C)-transfected mESCs, whereas they were readily detectable in the 
samples from C3H10Tl/2 cell cultures (Fig. 5D). Similarly, poly(I:C) can significantly 
induce expression of ICAMl in C3H10Tl/2 cells, but not in mESCs (Fig. 5C). 
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Figure 5. mESCs fail to express and produce IFNP, IL-6, and ICAMl in response to 
dsRNA. A-D, D3 mESCs and C3H10Tl/2 cells were treated with 300 ng/mL poly(l:C). 
A and B), mRNA levels ohested genes were analyzed by RT-qPCR. The results are 
expressed as fold-activation where the mRNA level in control cells is designated as 1. 
The results are means ± SD of three independent experiments. C) Expression profiles of 
ICAMl proteins in D3 mESCs and C3H10Tl/2 cells were determined by flow cytometry. 
The representative experiments in all panels were repeated at least twice with similar 
results. D) The culture medium collected at different time points was analyzed for IFNP 
by ELISA (detectable range 15.6-1000 pg/mL) and IL-6 by Luminex assay (detectable 
range 0.64-10000 pg/mL). ND: not detected. The values for IFNP are means ± SD of a 
representative experiment performed in triplicate. The values for IL-6 are average of a 
representative experiment performed in duplicate. 
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Relative Expression Levels of dsRNA Receptors in mESCs and C3H10Tl/2 Cells 
Innate antiviral responses are mediated by PRRs. These receptors induce the 
expression of IL-6 and IFNP by activating the transcription factors IRFs and NF-KB 
(Carty & Bowie, 2010; Matsumiya & Stafforini, 2010; Yoneyama & Fujita, 2007). 
Therefore, we analyzed the basal mRNA levels of PRR genes. Among the genes we 
tested, RIGI, MDA5 are viral dsRNA receptors which are expressed in the cytosol. TLR3 
is another viral dsRNA receptor, but it can express both on cell surface and in cytosol. 
We observed that they are much lower in mESCs than in C3H10Tl/2 cells (Fig. 6). This 
observation indicated that the negligible gene expression of IL-6 and IFNP in mESCs 
may be related to the low expression of PRRs. 
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Figure 6. The expression levels of RNA receptor genes in mESCs are much lower than in 
C3H10Tl/2 cells. Cells were plated at 30-40% confluence and cultured for 24h without 
treatment. The mRNA levels of tested genes were analyzed by RT-qPCR. The results are 
means ± SD of three independent experiments. 
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mESCs Are Susceptible to The Cytopathic Effects of LACY Infection 
While poly(I:C) has been used as a dsRNA viral analog (Offermann et al., 1995), 
it is an synthesized RNA that does not have biological activities associated with viral 
infection. To investigate the responsiveness of mESCs to live viral infection, we used 
LACY, a negative sense, single stranded RNA virus, to determine whether mESCs can 
respond to live viruses. Because the proliferation of mESCs is much faster than 
C3H10Tl/2 cells, mltiplicity of infection (M.O.I) of 10 and 1 were used in mESCs and 
C3H10Tl/2, respectively, in LACY infection experiments. The cell number was then 
measured by spectrophototmetry where optical density is proportional to cell number. 
Our results demonstrated that the LACY challenge reduced the cell viability of mESCs 
and C3Hl0Tl/2 cells (Fig. 7A and B), which was due to LACY-induced cytopathic 
effect (Fig. 7C). The viral infection of mESCs was confirmed by the expression of a 
LACY gene that encodes an M-segment protein (Ge protein) (Soldan, Hollidge, Wagner, 
Weber, & Gonzalez-Scarano, 2010). The infected cells were immunostained with 
monoclonal antibodies against the Ge protein (a gift from Dr. Samantha Soldan, 
University of Pennsylvania School of Medicine) followed by flow cytometry analysis. As 
shown in Fig. 7D, the expression of Ge protein was detected at 30 h and was significantly 
increased at 40 h post infection. 
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Figure 7. mESCs are susceptible to the cytopathic effects of LACV infection. A and B) 
D3 mESCs and C3H10Tl/2 cells were infected with LACV at M.0.1=10 and M.0.1=1, 
respectively, for 48h. Viable cells were determined at 48 h post infection by toluidine 
blue staining. The values for D3 mESCs are means ± SD of three independent 
experiments, while the value for C3H10Tl/2 cells is representative experiment performed 
three times. C) D3 mESCs and C3Hl0Tl/2 cells were infected with LACV (M.0.1=1). 
The cells were examined under a phase contrast microscope and photographed (400 x) at 
48 h for C3H10Tl/2 cells and 60 h for D3 cells. Arrows denote detaching dead cells. D) 
Detection of LACV Ge protein in D3 cells infected with LACV (MOI=lO) by flow 
cytometry. All experiments were performed at least twice with similar results. 
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mESCs Are Deficient in Expressing Type I IFN in Response to Viral Infection 
In order to address the question of whether or not a live virus can induce antiviral 
responses in mESCs, we infected mESCs and C3HI0T1/2 cells with LACY and analyzed 
the mRNA levels of antiviral genes. Even at very high M.O.I. (10), LACY only induced 
the negligible expression of type I IFNs in mESCs, but the induction in C3HI0T1/2 cells 
is drastic (Fig. 8). 
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Figure 8. mESCs are deficient in expressing type I IFN in response to viral infection. D3 
mESCs and C3H10Tl/2 cells were infected with LACY at M.0.1=10 and M.0.I.=1, 
respectively. The mRNA levels of the tested genes were determined by RT-qPCR 24 h 
post-infection. The results are means± SD of three independent experiments. 
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IFNP Inhibits LACV Replication and Protects mESCs from LACY-Induced Cytopathic 
Effects 
It is clear that the mESCs are deficient in IFN expression in response to viral 
infection and dsRNA. Since the expression of IFN and responsiveness to IFN are through 
different signaling pathways (as illustrated in Fig.2 and Fig.3). It would be interesting to 
see if mESCs can respond to IFN. We pretreated ESCs with IFNP followed by LACV 
infection. As shown in Fig. 9A, IFNP pretreatment protected mESCs from LACV 
induced cell death as judged by the increased number of viable cells after infection (Fig. 
9A). Furthermore, the result of LACV viral titer analysis indicated that IFNP treatment 
can significantly inhibit LACV replication in mESCs as judged by the reduced viral titer 
(Fig. 9B). 
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Figure 9. IFNP can protect mESCs from LACY-induced lytic cell death. A) D3 mESCs 
were pre-treated with IFNP (5000U/mL) for 24h. Then, the pretreated cells were infected 
with LACV at M.0.1=10 for 48h. Viable cells were determined at 48 h post infection by 
toluidine blue staining. B) The culture medium collected at 48 h post infection was 
analyzed for viral titer by plaque assay. The values are means± SD of three independent 
experiments. 
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IFNP Induces the Expression of dsRNA Receptors and Interferon-Stimulated Genes in 
mESCs 
To determine IFNP-induced cellular responses, we analyzed the expression level 
of type I IFN receptors (IFNARl) and genes that are known to be regulated by IFNP. As 
indicated in the Fig. lOA, IFNARl was readily detected at the mRNA level in mESC 
although it is lower than in C3H10Tl/2 cells. The mRNA levels of viral RNA receptors, 
including RIG-I, MDA5 and TLR3, were increased by IFNP treatment (Fig. 10B). 
Finally, we analyzed the expression of IFN~-stimulated gene 15 (ISG15), which was 
upregulated about 80 fold. Together, the results from these experiments confirm that 
mESCs are responsive to IFNP and that the signaling pathways that mediate the effects of 
IFNP are functional. 
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Figure 10. IFN~ induces the expression of dsRNA receptors and ISGs in mESCs. A) D3 
mESCs were plated at 30-40% confluence and cultured for 24 h without treatment. B and 
C) D3 mESCs were treated with IFN~ (5000 U/mL) for 24 h. The mRNA levels of tested 
genes were analyzed by RT-qPCR. The results of PRRs levels are means ± SD of three 
independent experiments. The values of IFNARl and ISGs come from a representative 
experiment. 
CHAPTER V 
DISCUSSION 
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In this study, we investigated the responses of mESC to a viral dsRNA analog and 
to live La Crosse Virus (LACV) infection. While both stimuli induced a robust IFNa/p 
expression in C3H10Tl/2 cells, they only induced very limited or no detectable 
transcription of IFNa/P in mESCs. These results suggest that mESCs are deficient in type 
I IFN expression, a central component of antiviral mechanisms in most types of somatic 
cells. 
We have found that the defective IFNa/P expression in mESCs could be 
explained by the low expression level of TLR3 although we could not rule out other 
mechanisms that may be involved. In some cell types, poly(l:C) can induce IFN via 
activation of TLR3 at the cell surface or in the endosomes (Stetson & Medzhitov, 2006; 
Meylan & Tschopp, 2006; Nasirudeen et al. , 2011). When transfected into the cells, 
poly(I:C) can induce robust IFN expression and other responses that are similar to those 
evoked by viral infection via cytoplasmic dsRNA receptors (Fortier et al., 2004; 
Matsumoto & Seya, 2008). mESCs were unresponsive to poly(I:C) that was directly 
added to the medium, likely due to the very low expression level of TLR3. However, 
poly(I:C) transfected into the mESCs showed a profound inhibitory effect on 
proliferation, a known effect of poly IC on many types of differentiated cells, indicating 
that the cytoplasmic receptors for poly(l:C) are active in mESCs. While we have 
provided substantial amount of evidence that poly(I:C) induced PKR activation is 
responsible for cell inhibition of ESCs, it is clear that the mechanisms mediating type I 
IFN is not functional in mESCs (Wang et al. , 2013). 
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It is generally believed that MDA5 and RIG-I play primary roles in mediating 
viral RNA induced IFNa/p expression in the cytoplasm (Stetson & Medzhitov, 2006; 
Nasirudeen et al., 2011), while PKR also contributes to and modulates this process 
(Garcia, Meurs, & Esteban, 2007; Samuel, 2001). Since MDA5 is expressed at negligible 
level in mESCs, it is conceivable that PKR and/or RIG-I may mediate the effects of 
transfected poly(I:C). However, the RIG-I signaling pathway seems to be inactive since 
silencing RIG-I did not affect the effects of poly IC and that 3p-ssRNA (5'-triphosphate 
single- stranded RNA), the best studied ligands of RIG-I (Pichlmair, et al., 2006; 
Yoneyama & Fujita, 2007), failed to induce IFN in mESCs (unpublished data). 
It was reported that LACY has developed certain mechanism to avoid the host 
innate antiviral responses. Repressing IFNa/P induction in host cells is one of such 
mechanisms (Haller, Kochs, & Weber, 2006). However, the capacity of LACY to repress 
IFNa/p induction seems to depend on the types of host cells, as we demonstrated in 
C3H10Tl/2 cells in which LACY can induce strong transcription of IFNP, but not in 
mESCs. The similar results were also found in dsRNA viral analog, West Nile Virus 
(WNV), and Sendai Virus (SeV) treated C3Hl0Tl/2 and mESCs (data not shown). It 
seems that the failure to express IFNa/P in mESCs could be an intrinsic property of 
mESCs, even though they are sensitive to the cytopathic effect of LACY infection. This 
conclusion is in line with similar observations, recently reported by Wash et al (Wash, 
Calabressi, Franz, Griffiths, & Goulding, 2012), that herpes simplex virus (HSV) and 
influenza virus (a negative sense, ssRNA virus) caused cytopathic effects without 
evoking type I IFN in mESCs. 
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The antiviral responses include two major types of cellular responses: pathogen 
recognition/IFN production and IFN positive feedback regulation (Takaoka & Yanai, 
2006). The best known function of type I IFN is their antiviral responses. In 
differentiated cells, IFN can enhance the antiviral responses of the cells by induction of 
several genes, known as IFN-stimulated genes (ISGs), which participate in various stages 
of antiviral responses. It is intriguing to find that mESCs do not have functional 
mechanism to synthesis IFN, yet they can respond IFN as demonstrated by the expression 
of the type I IFN receptor, expression of ISGs, and IFNP-priming induced protection 
mESCs from LACY-induced cytopathic effects. These observations support a conclusion 
that mESCs have functional mechanisms to detect and respond to IFNP although the 
cellular and molecular mechanisms involved remain to be investigated. 
In summary, our study demonstrates that expression of type I IFN, a crucial part 
of antiviral responses, is underdeveloped in mESCs, but the IFNP receiving and 
responding mechanisms are functional. This study may open up an important area in ESC 
research for understanding the development of antiviral mechanisms during 
embryogenesis and how the immunogenic signals affects ESC physiology. 
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